
Zhejiang Huahai Pharmaceutical Co., Ltd.
SSE:600521.SS
20.5 (CNY) • At close June 13, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Zhejiang Huahai Pharmaceutical Co., Ltd. |
Symbool | 600521.SS |
Munteenheid | CNY |
Prijs | 20.5 |
Beurswaarde | 30,549,707,764 |
Dividendpercentage | 1.38% |
52-weken bereik | 13.49 - 21.55 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Bao Hua Chen |
Website | https://www.huahaipharm.com |
An error occurred while fetching data.
Over Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)